The re-regulation of medicinal cannabis: is the TGA preparing to reassert control over THC? by Dr Teresa Nicoletti May 18, 2026May 19, 2026 Following her recent examination of the limitations of adverse event data in medicinal cannabis, Dr Teresa […]
Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026
SAS-B deep dive: approvals climb 26% in 2025 as flower overtakes oil and pastilles surge by Adam Sheldon January 13, 2026January 14, 2026
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
‘Houston, we have a bit of a problem’: Chief TGA medical adviser flags systemic issues across sector by Adam Sheldon November 18, 2025February 21, 2026
TGA reviewing 751 submissions as industry outlines roadmap for reform by Adam Sheldon October 8, 2025October 8, 2025
Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025
